Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends

BACKGROUND: Drug induced liver injury (DILI) is an increasing cause of acute liver injury especially with increasing need for pharmacotherapy of widening comorbidities amongst our ever-aging population. Uncertainty however remains regarding both acceptable and widely agreeable diagnostic algorithms...

Descripción completa

Detalles Bibliográficos
Autores principales: Danjuma, Mohammed Ibn-Mas’ud, Sajid, Jamal, Fatima, Haajra, Elzouki, Abdel-Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922486/
https://www.ncbi.nlm.nih.gov/pubmed/31852121
http://dx.doi.org/10.1097/MD.0000000000018322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922486/
https://www.ncbi.nlm.nih.gov/pubmed/31852121
http://dx.doi.org/10.1097/MD.0000000000018322

Ejemplares similares